Stryker is committed to internal innovation to develop products and services that improve outcomes and deliver greater cost savings and efficiencies and to augment efforts with focused acquisitions. The ability of Stryker's people to execute effectively is crucial for driving sales growth at the high end of the medtech industry. In 2014, Stryker achieved sales growth of 7.3%, with net sales primarily due to higher shipments of instruments products, trauma and extremities products, endoscopy products, neurotechnology products, and medical products. The company’s capital allocation strategy prioritizes acquisitions and share repurchases, reflecting a focus on resource allocation to enhance firm capabilities. Stryker’s investment in information technology infrastructure upgrades is aimed at supporting business growth and operational efficiencies. The company’s operational cash flow provides the primary source of cash to fund operating needs and capital expenditures, with excess operating cash used first to fund acquisitions. Stryker's capital expenditures are primarily directed towards integration of acquisitions, information technology infrastructure upgrades, capacity expansion, new product introductions, innovation, and cost savings. The management believes that its financial condition continues to be of high quality, evidenced by substantial cash generation from operations and access to capital markets at competitive rates. The company’s strategic decisions regarding acquisitions and capital expenditures are influenced by the need to enhance operational flexibility and maintain competitive advantage in a dynamic market environment. Stryker's commitment to innovation and effective execution is integral to its ability to respond to market dynamics and consumer demands, thereby enhancing its competitive positioning. The establishment of a European regional headquarters is expected to strengthen the brand in Europe, support global business growth, and provide operational efficiencies. The company’s approach to acquisitions reflects a strategic resource allocation aimed at leveraging technology capabilities and enhancing organizational effectiveness. Stryker's focus on developing new products and improving existing ones is essential for maintaining market agility and responding to changing business needs. The company’s financial activities, including investments in acquisitions and technology infrastructure, are designed to optimize performance and enhance overall business value. The management's emphasis on information management capability underscores the importance of providing data and information to users with appropriate levels of accuracy, timeliness, reliability, security, confidentiality, connectivity, and access. This capability is critical for supporting business strategies and work processes, enabling Stryker to mobilize and deploy IT-based resources effectively. The integration of technology into business processes is a key factor in Stryker's ongoing transformation into a competitive force within the medical technology industry, with a strong focus on enhancing organizational capabilities and achieving performance excellence.